Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Neurology | Ophthalmology | Pathology | Journal

Back to Journal Articles

Novel System Improves Retinal Prostheses in Mouse Model

Last Updated: August 14, 2012.

 

Prosthetic encoding system mimics normal retinal processing; allows mice to visually track a stimulus

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
A visual prosthetic that mimics normal retinal processing is able to improve retinal prosthetic capability in a mouse model of retinal degeneration, according to a study published online Aug. 13 in the Proceedings of the National Academy of Sciences.

TUESDAY, Aug. 14 (HealthDay News) -- A visual prosthetic that mimics normal retinal processing is able to improve retinal prosthetic capability in a mouse model of retinal degeneration, according to a study published online Aug. 13 in the Proceedings of the National Academy of Sciences.

Sheila Nirenberg, Ph.D., and Chethan Pandarinath, Ph.D., from Cornell University in New York City, developed a high-resolution visual prosthetic that converts visual input into the same patterns of action potentials normally produced by the retina. The device consists of an encoder, which converts visual input into the code used by the retinal ganglion cells, and a transducer, which drives the ganglion cells to fire as specified by the code.

The researchers found that, when the device was used in a mouse model of retinal degeneration, ganglion cell firing patterns were produced that matched those of normal retinas. Images reconstructed from the output of the encoder were highly reliable. Mice with the device were also able to visually track a stimulus.

"In sum, our results show that incorporating the code dramatically increases prosthetic capabilities," Nirenberg and Pandarinath conclude. "The coded output combined with high-resolution stimulation makes natural vision restoration possible."

The authors have a patent application filed through Cornell University.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Vandetanib Slows Progression of Advanced Thyroid Cancer Next: Pregnancy Ups Bleed Risk From Abnormal Brain Blood Vessels

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.